The Cigna Group (CI)
Cigna Profits Hit $1.5 Billion On Pharmacy And Health Services Growth
The Cigna Group reported $1.5 billion in second quarter profits as the diversified provider of medical insurance, pharmacy benefits and health services reaped new clients.
Cigna (CI) is a Top-Ranked Growth Stock: Should You Buy?
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Can Cigna (CI) Beat Q2 Earnings on Growing Pharmacy Revenues?
Cigna's (CI) second-quarter earnings are expected to benefit from rising premiums and pharmacy revenues, partially offset by rising expenses.
Healthy Profits: 7 Healthcare Stocks to Build a Lifetime of Wealth
There are a whole host of reasons to invest in healthcare stocks over the long term. The United States has an aging population.
Wall Street's Insights Into Key Metrics Ahead of Cigna (CI) Q2 Earnings
Beyond analysts' top -and-bottom-line estimates for Cigna (CI), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2024.
Is Cigna Group (CI) Outperforming Other Medical Stocks This Year?
Here is how Cigna (CI) and atai Life Sciences N.V. (ATAI) have performed compared to their sector so far this year.
Cigna (CI) Reports Next Week: Wall Street Expects Earnings Growth
Cigna (CI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
3 HMO Stocks Set to Thrive on a Varied Customer Base, Tech Investments
Rising premiums, technological advancements and increased demand for Medicare plans are expected to drive the performances of the Zacks Medical-HMO industry players. UNH, CI and CNC are poised to benefit from encouraging industry prospects.
Here's Why Cigna (CI) is a Strong Value Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
4 Healthcare Stocks Poised to Beat Q2 Earnings Estimates
Expanding aging population and the increasing demand for affordable health products are likely to have boosted the performance of healthcare stocks in Q2. CI, UHS, HCA & THC are potential outperformers.
Here's Why Cigna (CI) is a Strong Growth Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
4 Cheap Stocks to Buy Ahead of Earnings
Cigna, Merck, Toll Brothers, Medtronic could see shares gain after proving their earnings growth remains strong.
